Christian Dillon announced as Vice President of Biology at PhoreMost

pharmafile | June 30, 2021 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

PhoreMost has announced the appointment of Dr Christian Dillon as Vice President of Biology.

In this new role, Dr Dillon will work across all the company’s areas of interest, including oncology, targeted protein degradation, and neurodegeneration. Dillon joins PhoreMost from Cancer Research UK’s Therapeutic Discovery Laboratories where he was Associate Director, acting as programme director for multiple drug discovery alliances with pharmaceutical partners, leading both discovery projects and portfolios from concept through to candidate nomination.

Dillon said: “I am excited to join PhoreMost as it enters the next phase of its development, and to support the progression of exciting novel targets, towards ‘drugging the undruggable’.”

Related Content

No items found

Latest content